Psychiatric DisorderNCT05087472
Prevalence of Psychiatric Disorders in the Refugee Population of Turkey
An observational study of Psychiatric Disorder, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
Trial summary
The investigators are planning to diagnose psychiatric disorders in willing participants from the refugee population in Turkey. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Psychiatric Disorder
- How many people
- 0 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Dec 2021to 9 Dec 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Outpatients in a primary care clinic who have official refugee status
Who may be able to join
- Having official refugee status in Turkey, willing to participate in the study
Who cannot join
- Having any disability that prevents answering interviewers' questions
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kütahya Health Sciences University
Kütahya, 43100
About this study
The investigators are planning to diagnose psychiatric disorders in willing participants from the refugee population in Turkey.
- Conditions
- Psychiatric Disorder
- Medical subject headings
- Mental Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview
The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview designed to screen for DSM-5 and ICD-10 psychiatric disorders. It will be utilized on willing participants from Turkey's refugee population.
Measured: Through study completion, on average five months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2021
- Study start9 Dec 2021
- Primary completion9 Dec 2021
- Study completion9 Dec 2021
Why it stopped: Could not obtain MINI licence
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Psychiatric DisorderStudies of the same condition, open and under way.
- More trials run by Kutahya Health Sciences UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kutahya Health Sciences University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Suleyman Keles, MD, Kutahya Health Sciences University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05087472
- Sponsor's protocol ID
- 1
- Status last verified
- Dec 2021
- First submitted
- 25 Sep 2021
- Last updated
- 13 Dec 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Psychiatric Disorders in the Refugee Population of Turkey
- ClinicalTrials.gov ID
- NCT05087472
- Acronym / sponsor ID
- 1
- Conditions
- Psychiatric Disorder
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Could not obtain MINI licence
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Kutahya Health Sciences UniversityUniversity, hospital or other
- Study start
- 9 Dec 2021 (actual)
- Primary completion
- 9 Dec 2021 (actual)
- Study completion
- 9 Dec 2021 (actual)
- First posted
- 21 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators are planning to diagnose psychiatric disorders in willing participants from the refugee population in Turkey.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Outpatients in a primary care clinic who have official refugee status
Key inclusion criteria (1 listed)
- Having official refugee status in Turkey, willing to participate in the study
Key exclusion criteria (1 listed)
- Having any disability that prevents answering interviewers' questions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview
Time frame: Through study completion, on average five months
The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview designed to screen for DSM-5 and ICD-10 psychiatric disorders. It will be utilized on willing participants from Turkey's refugee population.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Dec 2021.
- Individual participant dataSharing planned: No
Related trials for Psychiatric Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Psychiatric Disorder, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 13 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview (time frame: Through study completion, on average five months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2021.